Preliminary embolization of the @entity432 to expand the applicability of XXXX repair.

@entity1 @entity323 @entity3816 @entity63 @entity1416 @entity439 @entity432 @entity250
PURPOSE: To evaluate the efficacy and safety of @entity1416 prior to @entity439 repair (EVAR). METHODS: A retrospective review was conducted of all 101 consecutive @entity1 (91 @entity1 ; mean age 73.4    8.7 years) who underwent preliminary embolization of 133 HAs    4 to 6 weeks prior to EVAR from January 2005 to August 2009. Fourteen @entity1 with 19 HAs were treated using coils, while 87 @entity1 were treated with Amplatzer Vascular Plugs (AVP) in 114 HAs. All the @entity1 were evaluated before discharge; at 1, 3, and 6 months; and annually thereafter to evaluate the clinical symptoms, potential endoleaks, and the @entity439 size. RESULTS: In the coil group, complete occlusion was achieved in 16 (84.2%) of 19 procedures. There were no acute @entity63 after @entity432 embolization or EVAR. Five (35.7%) @entity1 had buttock claudication and 2 (16.7%) of 12 @entity1 experienced new @entity323 after embolization. At a mean 42.2-month follow-up (range 14-58), 3 (21.4%) @entity1 had a type II leak via retrograde flow in the @entity432 without @entity439 growth and were under observation. In the AVP group, all 114 HAs in 87 @entity1 were successfully occluded; there was no device dislodgment or acute pelvic or limb @entity63 observed. Buttock claudication and new @entity250 developed in 12 (13.8%) @entity1 and 4 (5.1%) of 79 @entity1 after the procedure, respectively. During a mean 26.4-month follow-up (range 4-54), 2 (2.3%) @entity1 developed distal type I endoleaks after EVAR, but angiography confirmed that neither of the endoleaks was related to the vessel embolized with the AVP. Comparing the outcomes of the treatment groups, the AVP was placed with fewer @entity3816 (p = 0.013) and more complete occlusion (p = 0.01) than coil embolization. The rate of buttock claudication was lower in the AVP group (p = 0.042). CONCLUSION: @entity1416 prior to EVAR is safe and effective. In our experience, the AVP affords easier and more precise placement and provides more complete occlusion, with fewer intraoperative and postoperative @entity63 complications than coil embolization.
